Self-Help

What this tab establishes

The balance sheet is not the constraint. At March 31, 2026 The Trade Desk held $1.41 billion of cash and short-term investments, no funded debt, and an undrawn $750 million revolver running to 2031 [1] [2]. The constraint is arithmetic scale. Since February 2023 the company has committed $2.45 billion to retiring 45.9 million shares at an average of $53.23 against today's $17.29, and the share count is down only 4.0%, because stock compensation reissued 26.5 million of them.

The balance sheet against the problem's duration

Source: Q1 FY2026 Form 10-Q, Condensed Consolidated Balance Sheets [3] and Note 6—Debt [4].

Cash and equivalents were $878.4 million and short-term investments $527.5 million at March 31, 2026, against total current liabilities of $2.89 billion, of which $2.63 billion is accounts payable owed to inventory and data suppliers — the pass-through leg of a business that collects from agencies and pays media owners [5]. Working capital was $1.97 billion. There is no funded debt anywhere in the structure: the company reported no outstanding balance under its credit facility at December 31, 2025 and again at March 31, 2026, and cash paid for interest in FY2025 was $993 thousand — a letter-of-credit and commitment-fee figure, not a debt-service figure [6] [7]. The revolver has been drawn once in the company's history, for $143.0 million in 2020, repaid within the same year [8].

The financing arrangement changed shape in April 2026. The old $450 million facility was due to mature on June 15, 2026 [9]. On April 14, 2026 the company replaced it with a restated $750 million revolving facility maturing April 14, 2031, with a further $750 million accordion, collateralised by substantially all assets subject to release on reaching investment grade, priced at term SOFR plus 112.5 to 150 basis points, an undrawn fee of 12.5 to 20 basis points, and a maximum net-funded-debt-to-EBITDA covenant of 3.50 to 1.00 [10] [11]. Nothing was drawn at signing and nothing has been drawn since. Two facts sit either side of that: the terms improved, since the old facility priced at SOFR plus 125 to 225 basis points and charged 20 to 35 basis points undrawn; and the size rose 67% while the company was repurchasing stock and drawing down its cash reserves [12].

Refinancing risk at current rates does not arise, because there is nothing to refinance. Covenant risk is equally remote: FY2025 adjusted EBITDA of $1.20 billion against a 3.50x net-leverage test implies roughly $4.2 billion of permitted funded debt, more than five times the committed facility [13]. The company was in compliance with all covenants at both dates [14] [15].

The maturity ladder, year by year

With no funded debt outstanding, the only contractual maturity schedule in the footnotes is the lease ladder.

Source: FY2025 Form 10-K, Note 8—Leases, maturities of lease commitments as of December 31, 2025 [16]; no funded debt outstanding per Note 7—Debt [17].

Undiscounted lease commitments total $795.2 million, of which $291.0 million relates to leases not yet commenced; the present value of recognised lease liabilities is $436.3 million, with a weighted-average remaining term of 5.5 years at a 4.8% discount rate [18]. Alongside the leases sit other non-cancelable commitments for hosting, hardware and software of $226.7 million due in 2026 and $39.1 million in 2027 and thereafter, plus $92 million of new cloud and data commitments signed in January 2026 and running to 2028 [19]. Every one of those obligations is covered several times over by FY2025 operating cash flow of $992.7 million [20].

The company can outlast this problem for as long as it takes, and nothing on the liability side can force capital allocation away from repurchases. The fact that qualifies a purely comfortable reading is the trajectory of the cash pile rather than its level: cash plus short-term investments fell from $1.92 billion at December 2024 to $1.30 billion at December 2025 [21], because FY2025 repurchases of $1.38 billion exceeded FY2025 free cash flow of $795.7 million by $585 million [22] [23]. Receivables are lengthening too — days sales outstanding moved from 97 days exiting Q4 2024 [24] to approximately 100 days exiting Q4 2025 — so the cash balance is a seasonal figure inside a large gross receivable and payable book rather than a static reserve [25].

The repurchase record — executed, not authorized

The program is real, large and recent. It began in February 2023, when the board authorized $700 million and the then-CFO announced it on the Q4 2022 call: "our strong profitability and cash flow enables us to return capital to shareholders, with a $700 million share repurchase program" [26]. Authorizations have been topped up four times since — $647 million in February 2024, $564 million at the end of January 2025, $500 million in October 2025 and $350 million in February 2026, for $2.76 billion cumulatively authorized [27].

Sources: cash spent from the consolidated statements of cash flows [28] [29]; shares retired and period-end counts from the statements of stockholders' equity [30] [31] [32]; average price derived as recognised repurchase value, which is struck on a trade-date basis and includes the 1% excise tax, divided by shares retired. No repurchases occurred before the program was approved in February 2023.

Executed against authorized: $2.45 billion of repurchase value recognised, of which $2.43 billion had settled in cash through March 2026, against $2.76 billion authorized [33], with $327 million still available at March 31, 2026 [34]. This is not an authorization without execution. The CFO put the cumulative figure on the record on the Q3 2025 call: "Going back to our first authorization in 2023, the company has repurchased nearly $2 billion through our repurchase program, effectively offsetting dilution and reducing shares outstanding over that time" [35].

Prices paid against today's price

Source: average prices derived from shares retired and recognised repurchase value in the statements of stockholders' equity [36] [37]; current price of $17.29 at July 24, 2026 from the daily price series.

Across the whole program the weighted-average price paid is $53.23 — $2,445.8 million for 45.9 million shares. At $17.29 the company has paid 3.08 times today's quote for the stock it retired, a mark-to-market shortfall of about $1.65 billion. Two-thirds of the spend happened above $50 a share. That is the cost of running an opportunistic program into a chart that fell 88% from its December 2024 peak, and it is the strongest single fact against reading capital allocation as a source of shareholder value in this episode.

The dilution treadmill

The filings describe the purpose of the program in exactly one way: it "is designed to help offset the impact of future share dilution from employee stock issuances" [38]. The share-count record shows the description is accurate.

Sources: consolidated statements of stockholders' equity, FY2022 and FY2025 10-Ks and the Q1 FY2026 10-Q [39] [40] [41].

The arithmetic between the gross and the net: 45.9 million shares were bought and retired between February 2023 and March 2026, while the count fell from 490.5 million at December 2022 to 471.0 million at March 2026 — a reduction of 19.5 million, or 4.0%. The gap of 26.5 million shares was reissued to employees. Fifty-eight percent of every repurchase dollar went to standing still. Per share of net reduction the program cost $125.62 of cash, against a share price of $17.29.

The dilution being offset is not a rounding item. Stock-based compensation has run at roughly half a billion dollars a year for four straight years while free cash flow has been climbing toward it.

Adjusted FCF = reported free cash flow − stock-based compensation expense − trailing five-year average acquisition spend; derived from the consolidated statements of cash flows in the FY2022 and FY2025 10-Ks [42] [43]. The deterministic feature file records adjusted FCF as not computable because its cash-flow feed carries no stock-compensation field, so this series is computed from the filed statements and is not the feature file's figure.

FY2025 stock compensation of $490.6 million equalled 16.9% of revenue and 61.7% of reported free cash flow [44]. Adjusted free cash flow on the framework's definition is $795.7 million − $490.6 million − $3.5 million of five-year average acquisition spend, or $301.6 million — 3.5% of the $8.53 billion market capitalisation, against the 8 to 9% reference line the framework applies to a net-cash balance sheet. The computation of the yield itself belongs to Yield; what matters here is what $301.6 million buys.

There is a second-order effect worth recording. Grants are struck in dollars, so a falling share price issues more shares for the same expense. Restricted stock issued net of forfeitures and withholding was 1.83 million shares in Q1 2026 against 0.78 million in Q1 2025 — 2.3 times as many shares for 15% less expense [45] [46]. Options granted in Q1 2026 alone came to 2.68 million shares at a $25.30 strike, against 4.58 million for the whole of FY2025 at $52.11 [47] [48]. Behind that sits 106.8 million shares still available for grant at December 31, 2025, increased by a further 19.0 million on January 1, 2026 — together 26.7% of the shares outstanding [49]. The treadmill gets steeper as the price falls, which is when repurchases are supposed to be most valuable.

Where the framework's share-count condition lands

The framework excludes companies whose share count keeps rising on stock compensation or serial acquisition. The deterministic feature file records share_count_trend.rising: true, with a five-year compound growth rate of +0.15% a year. Serial acquisition is not the mechanism: acquisition spend was $13.3 million in FY2021 and $4.4 million in FY2025 against $2.9 billion of revenue [50] [51].

The filed record dates that trend precisely. The count rose in every fiscal year from 2019 through 2024 except for a 0.3% dip in 2023 — including 2024, when $234.8 million of repurchases was overwhelmed by issuance and the count rose 1.5% to 496.1 million [52]. It turned down in 2025 by 4.1%, and again in Q1 2026 by 1.0%. The turn was bought rather than earned: FY2025 repurchase spend was 1.7 times reported free cash flow and 4.6 times adjusted free cash flow, funded by drawing the cash pile down $618 million [53]. So the condition the framework screens for described this company through FY2024 and stopped describing it in FY2025, at prices above $50 a share, using balance-sheet cash rather than operating cash. How long it keeps not describing it is a function of that cash: $1.41 billion of net cash covers about 2.4 years of the FY2025 gap between repurchases and free cash flow, after which repurchases fall back toward $301.6 million a year, or 3.5% of the float at today's price.

Management's buyback intent, from the record

Across the last six calls the intent language is stable and bounded. In five of those six the CFO closed the capital-allocation paragraph the same way: the company will "continue opportunistic share repurchases, while also offsetting dilution from employee stock issuances" [54] [55] [56] [57] [58]. Asked on the Q4 2024 call about 2025 investment priorities, the then-CFO gave the fullest statement of philosophy on the record: "as I've always said, we take an opportunistic approach to our share repurchase program. We are guided by market conditions on our capital priorities" [59].

Debt paydown has never competed for the money, because there is no debt, and acquisitions have not competed either — $4.4 million of acquisition spend in FY2025 is the largest figure since 2021 [60]. What competes is capital expenditure: management framed 2026 as a year of disciplined reinvestment on both the Q4 2025 and Q1 2026 calls [61] [62], and purchases of property and equipment doubled to $197.0 million in FY2025 and ran at $112.7 million in Q1 2026 alone [63] [64].

Two absences belong in the record. No analyst asked a question about the buyback, the balance sheet or capital allocation on the Q3 2025, Q4 2025 or Q1 2026 calls; every reference to repurchases in those three calls sits in prepared remarks. And the sentence "we had no debt on the balance sheet," present in the Q3 2025 and Q4 2025 financial remarks, is absent from the Q1 2026 remarks delivered three weeks after the secured $750 million facility was signed [65] [66] [67]. The 10-Q confirms nothing was drawn, so that change is one of script rather than substance — but the script changed.

Execution against the low

The Q1 2026 monthly detail is the sharpest available test of "opportunistic," and the answer is mixed. The company bought nothing in January, with $150 million of authorization available, and nothing in February, with $500 million available after the February top-up, then bought all 7.1 million shares in March at an average of $24.31 [68]. The stock traded as low as $21.28 during the quarter. Quarterly deployment has also fallen as the price has fallen — $423 million in Q4 2025 at an average near $41, then $164 million in Q1 2026 at $24 [69] [70] [71]. The binding constraint looks like the authorization ceiling rather than conviction: $327 million was left at March 31, 2026, equal to 3.8% of the market capitalisation [72].

Insider buying

The founder-CEO put $148.1 million of his own cash into the stock over three trading days. Jeff Green bought 6,000,000 Class A shares in the open market on March 2, 3 and 4, 2026 at prices between $23.49 and $25.08, an average of $24.68, filed as code P purchases rather than option exercises [73]. Across the 152 Form 4 transactions in the record, his are the only open-market purchases [74]. He was buying in the same weeks the company was, at close to the same average price, and the stock now sits 30% below what he paid.

Set against it, four insiders sold into the same decline, none in comparable size. Kathryn Falberg, then a member of the audit committee [75] and a director since August 2016 [76], sold 152,828 shares at $30.45 and $30.48 on March 5, 2026 — the day after Green's last purchase — and resigned from the board on March 23 [77] [78]. Samantha Jacobson sold 53,681 shares at $21.14 on May 28, 2026, ten days after resigning as chief strategy officer [79] [80]. The other two sold earlier and smaller: the chief legal officer sold $4.7 million under a 10b5-1 plan in August 2025 and a director sold $68,000 in September 2025 [81]. Green's purchase is fourteen times the combined value of every insider sale in the record, and it is the strongest fact in this tab on the supportive side of the ledger.

The absurdity check

The feature file records float_retirement_years as not computable, because adjusted free cash flow could not be derived from its cash-flow feed. Computed from the filed statements instead:

Market capitalisation of $8,533 million at $17.29 on July 24, 2026, divided by FY2025 adjusted free cash flow of $301.6 million, gives 28.3 years to retire the entire float. On reported free cash flow of $795.7 million — before deducting the $490.6 million of stock compensation that is a real cost of keeping the engineers — the same calculation gives 10.7 years [82].

The framework's reference case is a price at which about three years of adjusted free cash flow buys the company. Twenty-eight is not that number, and neither is eleven.

The levered exception

The exception the framework allows for indebted companies requires a very high adjusted yield, around 25%, together with a demonstrated multi-year share-count reduction and free cash flow to revenue that is not deteriorating. The first leg settles it: the adjusted yield is 3.5%, not 25%, so the gate never opens. For completeness, the second leg is partly satisfied — a 5.1% reduction over five quarters, against a five-year trend that is still marginally upward — and the third is satisfied, with adjusted free cash flow to revenue improving from 2.9% in FY2023 to 10.4% in FY2025. Two of three would not be the exception in any case, and the exception is aimed at levered balance sheets; this one holds net cash, which places it on the 8 to 9% reference line rather than the 25% one.

Dividend

No dividend forms part of this case. The company has never declared or paid one, does not anticipate paying one, and the credit agreement restricts its ability to do so; the stated intention is to retain earnings for operations, expansion, or repurchases of Class A stock [83]. The dividend-coverage test does not apply.

Management credibility

Promise versus delivery

Five material commitments made two to four years ago, checked against what happened.

Sources: Q4 FY2022 [84], Q3 FY2023 [85] and Q2 FY2024 [86] transcripts; the Q4 2024 guidance as given on the Q3 FY2024 call [87], and the shortfall as acknowledged on the Q4 FY2024 call [88]; share counts from the statements of stockholders' equity [89].

Two of the five were delivered squarely, one was missed and owned, two are mixed. The ownership matters to the read. On February 12, 2025 the CEO opened the call with it: "for the first time in 33 quarters as a public company we fell short of our expectations… but for the first time in 8 years, we missed the expectations we set, and it was our fault" [90]. Since that miss the numeric guidance record has been clean: every quarterly revenue and adjusted EBITDA guide from Q1 2025 through Q1 2026 was met. One commitment is outstanding and worth watching — a full-year 2026 adjusted EBITDA margin of at least 40% against a Q1 2026 margin of 30%, which requires materially higher margins across the balance of the year [91]. That target is struck after adding back stock compensation [92]; FY2025 GAAP operating margin was 20.3% and Q1 2026 net margin 5.8% [93] [94].

The record is weakest on strategic claims that carried no date. The narrative through 2023 and 2024 asserted that share gains were independent of conditions; the narrative in 2026 attributes deceleration to conditions. On the Q4 2025 call the framing was "Even though we have not harvested most of those seeds, we are seeing green shoots and are extremely confident that we've made the right moves" [95]; on the Q1 2026 call it was "the macro environment has certainly become more complex in 2026" [96]. Neither carries a quantified path back to faster growth.

Insider economic ownership

The founder's stake is large and he added to it in cash. As of March 6, 2026 Green held 11,483,384 Class A and 42,071,879 Class B shares — 11.2% of the shares outstanding, worth about $926 million at $17.29 [97]. His FY2025 compensation was $27.4 million [98], and his 2021 performance option — 17.8 million shares at a $68.29 strike, with the next vesting tranche at $145 and the top tranche at $340 — carried no intrinsic value at December 31, 2025 and carries none today [99] [100]. On the framework's exclusion test — a promotional chief executive without skin in the game, managing to next quarter's number — the evidence runs the other way: the ownership is real, the one miss was owned, and a $148 million cash purchase at the lows is the opposite of an exit.

The governance facts that cut against it

The same holding carries 49.7% of total voting power, because Class B has ten votes a share [101]. In September 2025 stockholders approved an amendment extending the automatic conversion of Class B into Class A to December 22, 2035; on December 9, 2025 Nasdaq issued a letter of reprimand finding that the amendment violated its voting-rights rule, which the company disputes but did not appeal [102] [103]. The company also reincorporated from Delaware to Nevada, which remains the subject of a stockholder fiduciary-duty action [104].

A consolidated federal securities class action covering purchases from November 15, 2023 to August 8, 2025 alleges false and misleading statements and adds a Section 20A count alleging that the chief executive, then-chief financial officer and chief strategy officer traded on inside information during the class period; the motion to dismiss was pending at the FY2025 filing, and a derivative action is stayed behind it [105]. Management states that it believes the claims meritless.

The turnover is the hardest fact to read benignly. Four directors left between March 3 and April 3, 2026 — Gokul Rajaram, Alexander Kayyal, Kathryn Falberg and Lise Buyer [106] [107] — leaving the board at five [108] and out of compliance with Nasdaq's audit- and compensation-committee composition rules, with a cure deadline of September 21, 2026 [109]; replacements were appointed in April, June and July 2026 [110]. [111] The finance seat has turned over four times in eighteen months: Laura Schenkein, then Alex Kayyal from August 2025 [112], then Tahnil Davis as interim, then Nate Olmstead effective July 9, 2026 [113]. Kayyal's separation included a $400,000 relocation payment [114].

Taken together, this is not the promotional pattern the framework excludes: the misses are one rather than repeated, that one was owned in plain language, and insider ownership is 11.2% of the equity plus a $148 million cash purchase at the lows. It is a governance profile with a founder holding half the votes on a tenth of the economics, a board that emptied in five weeks, and unresolved securities litigation naming the officers who set the guidance. What would move the read either way is observable and dated: a full-year 2026 adjusted EBITDA margin at or above 40%, and whether the repurchase pace survives the exhaustion of the net cash that funded FY2025.